The Biotime SARS-CoV-2 IgG/IgM Rapid Qualitative Test is intended to qualify the SARS-CoV-2 IgG and IgM antibody in human plasma, serum or whole blood by colloidal gold immunochromatography assay. The test can be used as an aid detection to SARS-CoV-2 infection and thus caused COVID-19 disease.
The Dengue IgG/IgM Rapid Test is a rapid membrane based chromatographic immunoassay for qualitative and differential detection of IgG and IgM antibodies to all four serotypes (DEN-1, DEN-2, DEN- 3 and DEN-4) of Dengue virus in human serum, plasma or whole blood. It is intended to be used by professionals as a screening test and provides a preliminary test result to aid in the diagnosis of primary and secondary Dengue infection. For professional in vitro diagnostic use only.
The MPV IgG/IgM Rapid Test is a lateral flow chromatographic immunoassay for the qualitative detection and differentiation of IgM and IgG antibodies to Monkeypox Virus (MPV) in human serum, plasma, venous whole blood, or fingertip blood. It is intended for use as an aid in identifying individuals with an adaptive immune response to MPV, indicating recent or prior infection. At this time, it is unknown how long antibodies persist following infection and if the presence of antibodies confers protective immunity. The MPV IgG/IgM Rapid Test should not be used to diagnose acute MPV infection. For professional in vitro diagnostic use only.
IPv6 network supported 
